糖尿病病症:病原体,机制和治疗策略
Shivangi Dwivedi1, Mukesh Singh Sikarwar1
1College of Pharmacy, Teerthanker Mahaveer University, Moradabad, India.
糖尿病病 (DN) 是导致衰竭的主要原因. 了解其原因,诸如高血糖和炎症等机制,以及诸如RAAS抑制等治疗方法是管理这种糖尿病并发症的关键.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病病 (DN) 是全世界末期病 (ESRD) 的主要原因之一.
- 它显著增加了糖尿病患者的发病率和死亡率.
- DN源于复杂的相互作用,包括高血糖症,血液动力学变化,炎症,氧化应激和遗传学.
研究的目的:
- 为糖尿病病的病因,机制和治疗提供全面的审查.
- 为了阐明驱动DN进展的分子途径.
- 总结目前用于管理DN的治疗策略.
主要方法:
- 对糖尿病病现有文献的综述.
- 分析关键的病理机制,包括先进的糖化终产物 (AGEs),蛋白激酶C (PKC) 激活,以及氨酸- ангиотензин- 氨酸系统 (RAAS) 的过度表达.
- 检查炎症 (TGF-β,NF-κB) 和氧化应激的作用.
主要成果:
- 过高血糖症开始介质增殖和球基底膜的加厚.
- 淋巴细胞硬化,管管间纤维化和脏痕是渐进的结果.
- 炎症调解剂和氧化应激会加剧损伤和纤维化.
结论:
- 有效管理DN需要优化血糖控制和高血压.
- 使用 ACE 抑制剂或 ARBs 抑制雷宁- ангиотензин- 阿尔多斯特系统 (RAAS) 是至关重要的.
- 针对炎症和氧化途径可能为未来的治疗途径提供了目标.
更多相关视频
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
相关概念视频
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
